Germany Colloids Blood Plasma Market Insight
Published: 23 May 2026 | Report Format: Electronic (PDF)
Highly purified and recombinant forms of albumin have been made possible by advanced molecular fractionation techniques, thereby guaranteeing constant oncotic pressure support while avoiding any viral infections that could occur from human donors.
Germany Colloids Blood Plasma Market Insights and Forecasts to 2035
- In 2025, the Germany Colloids Blood Plasma Market stood at USD 2124.8 Million, establishing a strong base for future growth.
- It is anticipated to expand at a CAGR of 3.7% over 2025 to 2035, supported by the Oncotic stabilisation trend.
- The market is projected to reach approximately USD 3,049.7 Million by 2035, reflecting continuous long-term growth.
Notable Insights for the Germany Colloids Blood Plasma Market
- By product type, albumin-based colloids have the biggest share of the market, around 46–50% market share in 2025. This is probably because they are widely adopted in places, such as intensive care units, for liver disorders, and even for postoperative care procedures.
- By application side, trauma and emergency care is expected to lead the market, with a roughly 37–41% market share in 2025. That should be linked to rising road accidents, along with the constant need for urgent surgeries.
- Germany does around 16 million or more surgical procedures per year, so there is a noticeable need for colloid plasma expanders and albumin-based fluid management approaches, especially during the perioperative part of care.
Download the eBook (ToC)
- In Germany, roughly 58 to 62% of intensive care units use albumin-based colloid solutions as one of those advanced hemodynamic stabilisation methods for critical patient resuscitation protocols.
What Makes Decisions Advisors Research Unique?
1. Specific Sector Knowledge
Decisions Advisors provides targeted market intelligence in sectors such as health care, automobiles, chemicals, technology, industrial machinery, consumer goods, and future technologies with specific industry insights.
2. Approach of Data-based Forecast
This study utilizes an approach that includes primary interviews, proprietary databases, company assessments, trade data, and macro-economic figures for developing forecasts and analyzing trends in the marketplace.
3. Competitive Analysis and Benchmarking
Our reports give competitive information like company profiles, investments, innovations, SWOT analysis, M&A, and regional positioning, among others, to facilitate business decisions and investments
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Germany colloids blood plasma market, along with a comparative evaluation primarily based on their product offerings, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Germany Colloids Blood Plasma Market
- Grifols
- CSL Behring
- Baxter International
- Octapharma
- Fresenius Kabi
- Takeda Pharmaceutical Company
- Biotest AG
- Kedrion Biopharma
- LFB Group
- B. Braun Melsungen AG
Recent Developments:
- In January 2025, CSL Behring increased the capacity of plasma fractionation and albumin manufacturing throughout Europe and ensured adequate availability of product lines for critical and emergency care purposes.
Market Segmentation:
Germany Colloids Blood Plasma Market, By Product Type
- Albumin-Based Colloids
- Hydroxyethyl Starch (HES)
- Gelatin-Based Colloids
- Dextran-Based Colloids
Germany Colloids Blood Plasma Market, By Application
- Trauma & Emergency Care
- Surgical Procedures
- Intensive Care Units (ICU)
- Burn Treatment
Germany Colloids Blood Plasma Market, By End User
- Hospitals
- Blood Banks
- Speciality Clinics
- Ambulatory Surgical Centres
Germany Colloids Blood Plasma Market, By Distribution Channel
- Direct Supply Contracts
- Hospital Pharmacies
- Retail Pharmacies
- Online Medical Distribution
Expert Views:
Sustainability in Germany’s colloid blood plasma industry is projected as a result of growth in admissions to critical care units, an increase in the need for plasma-based products, development of emergency healthcare facilities, and improvements in fluid resuscitation technology.
Author: Govind and Krishna By Spherical Insights and Consulting